NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Beside's DR. Stupp's intent to ignore/downplay DCVax-L's impressive safety profile and unprecedented efficacy for rGBM patients, he also forgot to mention that this vaccine is beneficial for a substantial number of unmethylated GBM patients. According to the NYAS
presentation, of 131 unmethylated GBM patients 8 (6.1%) survived for 5(+) years. In contrast, the 5 year survival capacity for unmethylated GBM patients in the ECA's was non existent and I doubt that it was much better in helmet treated patients.